Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-031541

Chief Business Development Off sold 246,770 shares at $40.00 ($9,870,800)

  • Chief Business Development Off acquired 246,770 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BENZENO SHARON · Chief Business Development Off

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2020-05-19 Exercise or conversion : show line 1 in the form +60,000 $1.98 $118,800 60,000 D
2020-05-19 Exercise or conversion : show line 2 in the form +18,750 $6.32 $118,500 78,750 D
2020-05-19 Exercise or conversion : show line 3 in the form +15,416 $6.27 $96,658 94,166 D
2020-05-19 Exercise or conversion : show line 4 in the form +78,125 $6.55 $511,719 172,291 D
2020-05-19 Exercise or conversion : show line 5 in the form +49,479 $6.55 $324,087 221,770 D
2020-05-19 Exercise or conversion : show line 6 in the form +25,000 $7.27 $181,750 246,770 D
2020-05-19 Sale : show line 7 in the form −246,770 $40.00 $9,870,800 0 D
Open-market sales · 246,770 sh · avg $40.00 · $9,870,800

Table II: Derivative

6 lines
Date Transaction Shares Owned after D/I
2020-05-19 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −60,000 0 D
2020-05-19 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −18,750 1,250 D
2020-05-19 Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) −15,416 4,584 D
2020-05-19 Exercise or conversion : show line 11 in the form Stock Option (Right to Buy) −78,125 45,875 D
2020-05-19 Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) −49,479 75,521 D
2020-05-19 Exercise or conversion : show line 13 in the form Common Stock (Right to Buy) −25,000 50,000 D
Loading xslF345X03/doc4.xml…